

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 5.82934229 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.66906189 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 5.66906189 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.63454658 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.63454658 |
| 6 | urea metabolic process (GO:0019627) | 5.32272324 |
| 7 | regulation of protein activation cascade (GO:2000257) | 5.25397719 |
| 8 | low-density lipoprotein particle clearance (GO:0034383) | 5.02541913 |
| 9 | protein carboxylation (GO:0018214) | 5.02482371 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.02482371 |
| 11 | regulation of complement activation (GO:0030449) | 5.01448951 |
| 12 | urea cycle (GO:0000050) | 5.00509246 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 4.96470301 |
| 14 | regulation of fibrinolysis (GO:0051917) | 4.84732709 |
| 15 | nitrogen cycle metabolic process (GO:0071941) | 4.79407289 |
| 16 | epoxygenase P450 pathway (GO:0019373) | 4.73184479 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.63920086 |
| 18 | omega-hydroxylase P450 pathway (GO:0097267) | 4.63794172 |
| 19 | ethanol oxidation (GO:0006069) | 4.56260670 |
| 20 | acylglycerol catabolic process (GO:0046464) | 4.38052147 |
| 21 | neutral lipid catabolic process (GO:0046461) | 4.38052147 |
| 22 | triglyceride catabolic process (GO:0019433) | 4.36135759 |
| 23 | exogenous drug catabolic process (GO:0042738) | 4.32495045 |
| 24 | plasma lipoprotein particle clearance (GO:0034381) | 4.27809716 |
| 25 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.23457453 |
| 26 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.23457453 |
| 27 | regulation of cholesterol esterification (GO:0010872) | 4.08536009 |
| 28 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.06781023 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 4.01306181 |
| 30 | glyoxylate metabolic process (GO:0046487) | 4.00880389 |
| 31 | drug catabolic process (GO:0042737) | 3.99405830 |
| 32 | regulation of plasminogen activation (GO:0010755) | 3.93865660 |
| 33 | fibrinolysis (GO:0042730) | 3.86283974 |
| 34 | fatty acid homeostasis (GO:0055089) | 3.75475659 |
| 35 | ethanol metabolic process (GO:0006067) | 3.72801999 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 3.70683944 |
| 37 | negative regulation of sterol transport (GO:0032372) | 3.70683944 |
| 38 | plasma lipoprotein particle remodeling (GO:0034369) | 3.66727404 |
| 39 | protein-lipid complex remodeling (GO:0034368) | 3.66727404 |
| 40 | macromolecular complex remodeling (GO:0034367) | 3.66727404 |
| 41 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.61999228 |
| 42 | acylglycerol homeostasis (GO:0055090) | 3.56920095 |
| 43 | triglyceride homeostasis (GO:0070328) | 3.56920095 |
| 44 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.56322064 |
| 45 | acute-phase response (GO:0006953) | 3.48267541 |
| 46 | negative regulation of lipase activity (GO:0060192) | 3.46912233 |
| 47 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.43864271 |
| 48 | blood coagulation, intrinsic pathway (GO:0007597) | 3.42655221 |
| 49 | cholesterol efflux (GO:0033344) | 3.42363771 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 3.38728953 |
| 51 | regulation of cholesterol homeostasis (GO:2000188) | 3.38303984 |
| 52 | phospholipid efflux (GO:0033700) | 3.37492669 |
| 53 | glutamate metabolic process (GO:0006536) | 3.37000864 |
| 54 | diacylglycerol metabolic process (GO:0046339) | 3.32622683 |
| 55 | NADH metabolic process (GO:0006734) | 3.31463687 |
| 56 | regulation of cholesterol metabolic process (GO:0090181) | 3.26260479 |
| 57 | positive regulation of lipid catabolic process (GO:0050996) | 3.21253358 |
| 58 | glycerolipid catabolic process (GO:0046503) | 3.20615151 |
| 59 | proline metabolic process (GO:0006560) | 3.19859979 |
| 60 | opsonization (GO:0008228) | 3.18728560 |
| 61 | protein activation cascade (GO:0072376) | 3.14272224 |
| 62 | aromatic amino acid family catabolic process (GO:0009074) | 3.12289731 |
| 63 | bile acid metabolic process (GO:0008206) | 3.11783378 |
| 64 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.10679209 |
| 65 | high-density lipoprotein particle remodeling (GO:0034375) | 3.10175372 |
| 66 | negative regulation of blood coagulation (GO:0030195) | 3.09100005 |
| 67 | negative regulation of hemostasis (GO:1900047) | 3.09100005 |
| 68 | plasma lipoprotein particle assembly (GO:0034377) | 3.08568240 |
| 69 | regulation of apoptotic cell clearance (GO:2000425) | 3.08399136 |
| 70 | drug metabolic process (GO:0017144) | 3.08202198 |
| 71 | bile acid biosynthetic process (GO:0006699) | 3.07482389 |
| 72 | intestinal cholesterol absorption (GO:0030299) | 3.05656943 |
| 73 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.05573389 |
| 74 | negative regulation of protein activation cascade (GO:2000258) | 3.05536346 |
| 75 | plasma lipoprotein particle organization (GO:0071827) | 3.05209766 |
| 76 | protein-lipid complex assembly (GO:0065005) | 3.03562658 |
| 77 | protein-lipid complex subunit organization (GO:0071825) | 3.02682993 |
| 78 | regulation of cholesterol storage (GO:0010885) | 3.02214946 |
| 79 | serine family amino acid catabolic process (GO:0009071) | 2.98313842 |
| 80 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.98011596 |
| 81 | complement activation (GO:0006956) | 2.97649129 |
| 82 | triglyceride metabolic process (GO:0006641) | 2.97425790 |
| 83 | complement activation, classical pathway (GO:0006958) | 2.92542355 |
| 84 | acetyl-CoA metabolic process (GO:0006084) | 2.92370557 |
| 85 | regulation of triglyceride metabolic process (GO:0090207) | 2.91151127 |
| 86 | tricarboxylic acid metabolic process (GO:0072350) | 2.87658337 |
| 87 | negative regulation of lipid transport (GO:0032369) | 2.87354631 |
| 88 | tyrosine metabolic process (GO:0006570) | 2.87077895 |
| 89 | acylglycerol metabolic process (GO:0006639) | 2.86679340 |
| 90 | reverse cholesterol transport (GO:0043691) | 2.84828063 |
| 91 | neutral lipid metabolic process (GO:0006638) | 2.81644562 |
| 92 | negative regulation of coagulation (GO:0050819) | 2.81276240 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 2.79755979 |
| 94 | response to mercury ion (GO:0046689) | 2.79527994 |
| 95 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.78737636 |
| 96 | positive regulation of blood coagulation (GO:0030194) | 2.77220675 |
| 97 | positive regulation of hemostasis (GO:1900048) | 2.77220675 |
| 98 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.75870067 |
| 99 | negative regulation of wound healing (GO:0061045) | 2.74674168 |
| 100 | positive regulation of steroid metabolic process (GO:0045940) | 2.70972856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.81591793 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.64214737 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.72148129 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.68515766 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.25148836 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.22335075 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.03986006 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.91150686 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.74445370 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.71607786 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.59041992 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.52666745 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.46102144 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.34377368 |
| 15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.29124258 |
| 16 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.26787214 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.19286468 |
| 18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.15318685 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.97663484 |
| 20 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.97086767 |
| 21 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.87638446 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85334479 |
| 23 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.72805165 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.71489003 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.70789815 |
| 26 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69058782 |
| 27 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.65976157 |
| 28 | KDM2B_26808549_Chip-Seq_K562_Human | 1.62826686 |
| 29 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.62423064 |
| 30 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53730086 |
| 31 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.51652875 |
| 32 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.50607122 |
| 33 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.47070900 |
| 34 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.45898084 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.44967471 |
| 36 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.44342115 |
| 37 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.43510630 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.43433397 |
| 39 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42938726 |
| 40 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.42834707 |
| 41 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.41843216 |
| 42 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.39538130 |
| 43 | P68_20966046_ChIP-Seq_HELA_Human | 1.39299899 |
| 44 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.37490518 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.36497157 |
| 46 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34810081 |
| 47 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.33607042 |
| 48 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.33321476 |
| 49 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.32761712 |
| 50 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.32009213 |
| 51 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.30489239 |
| 52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27530276 |
| 53 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.25972822 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20843424 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17849163 |
| 56 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17231451 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16504863 |
| 58 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14124182 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12860318 |
| 60 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12386278 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11295327 |
| 62 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08424654 |
| 63 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07542173 |
| 64 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.05622039 |
| 65 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04942686 |
| 66 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04569886 |
| 67 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.04131333 |
| 68 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.00780088 |
| 69 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99765883 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99068163 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.97439342 |
| 72 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97306691 |
| 73 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95642947 |
| 74 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95642947 |
| 75 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95156351 |
| 76 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.94957210 |
| 77 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.94804625 |
| 78 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.94615514 |
| 79 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.94555121 |
| 80 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93826329 |
| 81 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.91726367 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91472856 |
| 83 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91145643 |
| 84 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.90791364 |
| 85 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89599975 |
| 86 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.89558259 |
| 87 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.89224687 |
| 88 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.88558746 |
| 89 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.88202170 |
| 90 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.86750022 |
| 91 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.86496873 |
| 92 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86155786 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85773701 |
| 94 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.85722194 |
| 95 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.85722194 |
| 96 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.84945602 |
| 97 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84869674 |
| 98 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84859455 |
| 99 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.84727462 |
| 100 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.84499302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.32175416 |
| 2 | MP0005360_urolithiasis | 4.82043426 |
| 3 | MP0005670_abnormal_white_adipose | 4.20916991 |
| 4 | MP0005365_abnormal_bile_salt | 4.04847930 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.30547880 |
| 6 | MP0009840_abnormal_foam_cell | 3.11529802 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.07514218 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.03708866 |
| 9 | MP0003191_abnormal_cellular_cholesterol | 3.00226786 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.80587156 |
| 11 | MP0005666_abnormal_adipose_tissue | 2.73413558 |
| 12 | MP0002971_abnormal_brown_adipose | 2.32426446 |
| 13 | MP0003868_abnormal_feces_composition | 2.16829551 |
| 14 | MP0003329_amyloid_beta_deposits | 2.14819849 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.12178531 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 2.08108430 |
| 17 | MP0003195_calcinosis | 2.06678216 |
| 18 | MP0005375_adipose_tissue_phenotype | 2.00072778 |
| 19 | MP0004130_abnormal_muscle_cell | 1.99282968 |
| 20 | MP0005451_abnormal_body_composition | 1.98540408 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.91856978 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.84900811 |
| 23 | MP0003879_abnormal_hair_cell | 1.76793885 |
| 24 | MP0005332_abnormal_amino_acid | 1.72378050 |
| 25 | MP0003690_abnormal_glial_cell | 1.71112192 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.66762060 |
| 27 | MP0000604_amyloidosis | 1.63460873 |
| 28 | MP0000609_abnormal_liver_physiology | 1.62559718 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.60728191 |
| 30 | MP0000566_synostosis | 1.60336121 |
| 31 | MP0001661_extended_life_span | 1.48606408 |
| 32 | MP0003252_abnormal_bile_duct | 1.44380407 |
| 33 | MP0000003_abnormal_adipose_tissue | 1.43022805 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.37256393 |
| 35 | MP0004272_abnormal_basement_membrane | 1.33590969 |
| 36 | MP0005409_darkened_coat_color | 1.33010171 |
| 37 | MP0003075_altered_response_to | 1.32232999 |
| 38 | MP0000751_myopathy | 1.28129657 |
| 39 | MP0005334_abnormal_fat_pad | 1.26321162 |
| 40 | MP0002089_abnormal_postnatal_growth/wei | 1.26040455 |
| 41 | MP0004858_abnormal_nervous_system | 1.24006162 |
| 42 | MP0002970_abnormal_white_adipose | 1.23760737 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.23601024 |
| 44 | MP0004019_abnormal_vitamin_homeostasis | 1.20445447 |
| 45 | MP0009115_abnormal_fat_cell | 1.18188917 |
| 46 | MP0010368_abnormal_lymphatic_system | 1.16809911 |
| 47 | MP0005083_abnormal_biliary_tract | 1.15635329 |
| 48 | MP0004859_abnormal_synaptic_plasticity | 1.15025257 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.11133651 |
| 50 | MP0005535_abnormal_body_temperature | 1.10359760 |
| 51 | MP0004270_analgesia | 1.04988082 |
| 52 | MP0001849_ear_inflammation | 1.04740773 |
| 53 | MP0010234_abnormal_vibrissa_follicle | 1.02545805 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 0.98760805 |
| 55 | MP0005076_abnormal_cell_differentiation | 0.97932034 |
| 56 | MP0005257_abnormal_intraocular_pressure | 0.97143065 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 0.96772441 |
| 58 | MP0006138_congestive_heart_failure | 0.95482540 |
| 59 | MP0003959_abnormal_lean_body | 0.94428323 |
| 60 | MP0000920_abnormal_myelination | 0.94132270 |
| 61 | MP0002249_abnormal_larynx_morphology | 0.93912289 |
| 62 | MP0005448_abnormal_energy_balance | 0.93567170 |
| 63 | MP0008260_abnormal_autophagy | 0.91438570 |
| 64 | MP0001915_intracranial_hemorrhage | 0.90813723 |
| 65 | MP0000678_abnormal_parathyroid_gland | 0.85662835 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 0.84948429 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.84755686 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 0.83743601 |
| 69 | MP0003634_abnormal_glial_cell | 0.83687586 |
| 70 | MP0009643_abnormal_urine_homeostasis | 0.83438028 |
| 71 | MP0002909_abnormal_adrenal_gland | 0.81944997 |
| 72 | MP0001764_abnormal_homeostasis | 0.81686122 |
| 73 | MP0005023_abnormal_wound_healing | 0.81512572 |
| 74 | MP0000579_abnormal_nail_morphology | 0.78948048 |
| 75 | MP0002896_abnormal_bone_mineralization | 0.78307018 |
| 76 | MP0003011_delayed_dark_adaptation | 0.76847490 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.75774039 |
| 78 | MP0003186_abnormal_redox_activity | 0.73706188 |
| 79 | MP0000467_abnormal_esophagus_morphology | 0.73384837 |
| 80 | MP0003123_paternal_imprinting | 0.72536649 |
| 81 | MP0002796_impaired_skin_barrier | 0.72509889 |
| 82 | MP0009672_abnormal_birth_weight | 0.71324123 |
| 83 | MP0000598_abnormal_liver_morphology | 0.71180113 |
| 84 | MP0005452_abnormal_adipose_tissue | 0.71093773 |
| 85 | MP0004233_abnormal_muscle_weight | 0.70057959 |
| 86 | MP0002060_abnormal_skin_morphology | 0.69663893 |
| 87 | MP0008874_decreased_physiological_sensi | 0.67081924 |
| 88 | MP0000013_abnormal_adipose_tissue | 0.65727260 |
| 89 | MP0000747_muscle_weakness | 0.63334779 |
| 90 | MP0005423_abnormal_somatic_nervous | 0.62308050 |
| 91 | MP0003633_abnormal_nervous_system | 0.62273126 |
| 92 | MP0009053_abnormal_anal_canal | 0.61544657 |
| 93 | MP0003632_abnormal_nervous_system | 0.60302748 |
| 94 | MP0003631_nervous_system_phenotype | 0.57442130 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.57408992 |
| 96 | MP0004087_abnormal_muscle_fiber | 0.54729192 |
| 97 | MP0005647_abnormal_sex_gland | 0.54203028 |
| 98 | MP0002064_seizures | 0.53984639 |
| 99 | MP0003953_abnormal_hormone_level | 0.53916126 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.52970312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 6.82449163 |
| 2 | Complement deficiency (HP:0004431) | 6.71852241 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.10054483 |
| 4 | Abnormality of complement system (HP:0005339) | 5.57161213 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.52315527 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 4.79567111 |
| 7 | Xanthomatosis (HP:0000991) | 4.49635879 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 4.33147415 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.23113846 |
| 10 | Joint hemorrhage (HP:0005261) | 4.09153733 |
| 11 | Conjugated hyperbilirubinemia (HP:0002908) | 3.91383062 |
| 12 | Glomerulonephritis (HP:0000099) | 3.81591390 |
| 13 | Hypercholesterolemia (HP:0003124) | 3.54928556 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.46631041 |
| 15 | Intrahepatic cholestasis (HP:0001406) | 3.36726332 |
| 16 | Hemorrhage of the eye (HP:0011885) | 3.30546702 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 3.21238938 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.19079827 |
| 19 | Abnormality of the common coagulation pathway (HP:0010990) | 3.03344784 |
| 20 | Mitral stenosis (HP:0001718) | 2.90059754 |
| 21 | Abnormality of the intrinsic pathway (HP:0010989) | 2.83352118 |
| 22 | Myocardial infarction (HP:0001658) | 2.80475752 |
| 23 | Neurofibrillary tangles (HP:0002185) | 2.78208242 |
| 24 | Cerebral inclusion bodies (HP:0100314) | 2.74826940 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.74029525 |
| 26 | Hypertriglyceridemia (HP:0002155) | 2.70980038 |
| 27 | Epidermoid cyst (HP:0200040) | 2.70675786 |
| 28 | Back pain (HP:0003418) | 2.69146140 |
| 29 | Nephritis (HP:0000123) | 2.68224051 |
| 30 | Skin nodule (HP:0200036) | 2.55658050 |
| 31 | Abnormality of the Achilles tendon (HP:0005109) | 2.54101859 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.51683869 |
| 33 | Axonal loss (HP:0003447) | 2.51255955 |
| 34 | Acanthosis nigricans (HP:0000956) | 2.49920927 |
| 35 | Vertebral compression fractures (HP:0002953) | 2.47551852 |
| 36 | Vascular calcification (HP:0004934) | 2.45528835 |
| 37 | Spontaneous abortion (HP:0005268) | 2.43112729 |
| 38 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.38212660 |
| 39 | Abnormal gallbladder physiology (HP:0012438) | 2.35934979 |
| 40 | Cholecystitis (HP:0001082) | 2.35934979 |
| 41 | Protrusio acetabuli (HP:0003179) | 2.35141125 |
| 42 | Cardiovascular calcification (HP:0011915) | 2.26681146 |
| 43 | Fat malabsorption (HP:0002630) | 2.21900302 |
| 44 | Abnormality of carpal bone ossification (HP:0006257) | 2.16498529 |
| 45 | Amyloidosis (HP:0011034) | 2.15009172 |
| 46 | Premature rupture of membranes (HP:0001788) | 2.13035017 |
| 47 | Hyperammonemia (HP:0001987) | 2.12503503 |
| 48 | Neonatal onset (HP:0003623) | 2.11833096 |
| 49 | Cholelithiasis (HP:0001081) | 2.09803192 |
| 50 | Cerebral aneurysm (HP:0004944) | 2.08526542 |
| 51 | Achilles tendon contracture (HP:0001771) | 2.03378845 |
| 52 | Distal upper limb amyotrophy (HP:0007149) | 1.97716531 |
| 53 | Upper limb amyotrophy (HP:0009129) | 1.97716531 |
| 54 | Hepatocellular carcinoma (HP:0001402) | 1.92435984 |
| 55 | Myokymia (HP:0002411) | 1.86583369 |
| 56 | Abnormal ossification of hand bones (HP:0005921) | 1.86055511 |
| 57 | Ulnar bowing (HP:0003031) | 1.85500992 |
| 58 | Retinal atrophy (HP:0001105) | 1.84307419 |
| 59 | Rickets (HP:0002748) | 1.84060505 |
| 60 | Abnormal gallbladder morphology (HP:0012437) | 1.82771248 |
| 61 | Bronchomalacia (HP:0002780) | 1.81720101 |
| 62 | Short nail (HP:0001799) | 1.78069401 |
| 63 | Neonatal death (HP:0003811) | 1.78035929 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76879532 |
| 65 | Flat acetabular roof (HP:0003180) | 1.75528798 |
| 66 | Purpura (HP:0000979) | 1.75500935 |
| 67 | Mucopolysacchariduria (HP:0008155) | 1.74304856 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.74304856 |
| 69 | Cervical subluxation (HP:0003308) | 1.72533010 |
| 70 | Abnormal delivery (HP:0001787) | 1.72481985 |
| 71 | Distal lower limb muscle weakness (HP:0009053) | 1.71578813 |
| 72 | Shallow orbits (HP:0000586) | 1.70805697 |
| 73 | Atrophic scars (HP:0001075) | 1.70417505 |
| 74 | Hyperacusis (HP:0010780) | 1.69589556 |
| 75 | Obstructive sleep apnea (HP:0002870) | 1.68579607 |
| 76 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.64960021 |
| 77 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.64960021 |
| 78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.64960021 |
| 79 | Atrioventricular block (HP:0001678) | 1.64937668 |
| 80 | Stridor (HP:0010307) | 1.64897916 |
| 81 | Growth hormone excess (HP:0000845) | 1.64862145 |
| 82 | Oligomenorrhea (HP:0000876) | 1.64697906 |
| 83 | Insulin resistance (HP:0000855) | 1.63325798 |
| 84 | Delayed CNS myelination (HP:0002188) | 1.63017646 |
| 85 | Pathologic fracture (HP:0002756) | 1.62480243 |
| 86 | Supranuclear gaze palsy (HP:0000605) | 1.62465089 |
| 87 | Elevated alkaline phosphatase (HP:0003155) | 1.62320795 |
| 88 | Steatorrhea (HP:0002570) | 1.61311016 |
| 89 | Advanced eruption of teeth (HP:0006288) | 1.60848668 |
| 90 | Reticulocytosis (HP:0001923) | 1.60653367 |
| 91 | Generalized aminoaciduria (HP:0002909) | 1.60161068 |
| 92 | Paraparesis (HP:0002385) | 1.60062613 |
| 93 | Turricephaly (HP:0000262) | 1.59967949 |
| 94 | Increased connective tissue (HP:0009025) | 1.57094164 |
| 95 | Hyperbilirubinemia (HP:0002904) | 1.57012715 |
| 96 | Esophageal varix (HP:0002040) | 1.55943902 |
| 97 | Hydroxyprolinuria (HP:0003080) | 1.55069798 |
| 98 | Abnormality of proline metabolism (HP:0010907) | 1.55069798 |
| 99 | Abnormality of the gallbladder (HP:0005264) | 1.54598949 |
| 100 | Abnormality of nucleobase metabolism (HP:0010932) | 1.54426017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.26188367 |
| 2 | SIK1 | 3.69629163 |
| 3 | RIPK1 | 3.40790508 |
| 4 | ERN1 | 3.00538838 |
| 5 | ICK | 2.86219733 |
| 6 | TESK1 | 2.28148615 |
| 7 | PRPF4B | 2.19835049 |
| 8 | ARAF | 2.19726960 |
| 9 | MST1R | 2.19329510 |
| 10 | EPHA2 | 2.12155096 |
| 11 | SMG1 | 2.07053161 |
| 12 | IRAK3 | 2.02748769 |
| 13 | LATS2 | 1.94674333 |
| 14 | FGFR4 | 1.94522722 |
| 15 | CAMK1D | 1.94093666 |
| 16 | EEF2K | 1.66101919 |
| 17 | NTRK1 | 1.58707943 |
| 18 | NME2 | 1.56840857 |
| 19 | PDGFRA | 1.55917601 |
| 20 | PRKD3 | 1.54073817 |
| 21 | PIM2 | 1.48382287 |
| 22 | PKN2 | 1.46672489 |
| 23 | EPHA4 | 1.46544973 |
| 24 | LMTK2 | 1.46322360 |
| 25 | CAMK1G | 1.32185587 |
| 26 | DDR2 | 1.31583649 |
| 27 | PTK2 | 1.30555159 |
| 28 | PDPK1 | 1.30285440 |
| 29 | EPHB2 | 1.28237357 |
| 30 | PDK2 | 1.24180617 |
| 31 | MET | 1.21162316 |
| 32 | ABL2 | 1.19221636 |
| 33 | NTRK3 | 1.17849760 |
| 34 | KSR2 | 1.14010257 |
| 35 | MAP3K9 | 1.11190650 |
| 36 | PAK6 | 1.05996684 |
| 37 | MTOR | 0.99542095 |
| 38 | CAMKK1 | 0.99074913 |
| 39 | PAK4 | 0.98292462 |
| 40 | TAOK2 | 0.97833831 |
| 41 | MAP3K11 | 0.96192835 |
| 42 | PRKAA2 | 0.93537792 |
| 43 | MAP3K6 | 0.93402893 |
| 44 | CDK12 | 0.93252363 |
| 45 | TYRO3 | 0.92106861 |
| 46 | SCYL2 | 0.83249199 |
| 47 | MARK2 | 0.81827731 |
| 48 | DAPK2 | 0.81739774 |
| 49 | BRAF | 0.80393220 |
| 50 | TESK2 | 0.80109981 |
| 51 | CAMK2G | 0.79651663 |
| 52 | STK38 | 0.77744455 |
| 53 | TTN | 0.76471918 |
| 54 | PTK6 | 0.75954398 |
| 55 | CAMK1 | 0.75791120 |
| 56 | RET | 0.73403890 |
| 57 | LIMK1 | 0.73001376 |
| 58 | MAP3K1 | 0.70951855 |
| 59 | BMX | 0.70636586 |
| 60 | CAMK2B | 0.70542826 |
| 61 | PHKG1 | 0.69168140 |
| 62 | PHKG2 | 0.69168140 |
| 63 | MAP3K3 | 0.68372132 |
| 64 | MAPK12 | 0.68292584 |
| 65 | MAPK11 | 0.66692761 |
| 66 | MAPKAPK3 | 0.66580065 |
| 67 | TGFBR2 | 0.66394358 |
| 68 | PDK1 | 0.64371554 |
| 69 | PRKG2 | 0.58948782 |
| 70 | RPS6KA2 | 0.58711700 |
| 71 | PRKAA1 | 0.58233243 |
| 72 | AKT2 | 0.57393721 |
| 73 | PRKD2 | 0.57019487 |
| 74 | TAOK1 | 0.56576327 |
| 75 | MAP3K2 | 0.55273113 |
| 76 | NEK6 | 0.54238448 |
| 77 | MAP2K1 | 0.54117159 |
| 78 | SGK494 | 0.54086238 |
| 79 | SGK223 | 0.54086238 |
| 80 | CDK15 | 0.54084282 |
| 81 | GRK5 | 0.52277460 |
| 82 | SGK3 | 0.52263574 |
| 83 | DAPK1 | 0.49600981 |
| 84 | DAPK3 | 0.49558586 |
| 85 | MARK1 | 0.48763040 |
| 86 | CDK11A | 0.48648631 |
| 87 | MAPK4 | 0.47374017 |
| 88 | CDK6 | 0.47322449 |
| 89 | CAMKK2 | 0.46576521 |
| 90 | CDK18 | 0.46380757 |
| 91 | PRKACG | 0.46166205 |
| 92 | CDC42BPA | 0.44913939 |
| 93 | MAP2K4 | 0.44897800 |
| 94 | UHMK1 | 0.44387320 |
| 95 | PAK2 | 0.43156408 |
| 96 | MOS | 0.42801570 |
| 97 | BRSK1 | 0.42356839 |
| 98 | GSK3A | 0.41707748 |
| 99 | EPHB1 | 0.40014432 |
| 100 | MAP2K2 | 0.39230471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.50820465 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.27421705 |
| 3 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.94869788 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.81555439 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.52127065 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.51995146 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.38862175 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.26676397 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.24131043 |
| 10 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.21564528 |
| 11 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.20341094 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.08371919 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.01357462 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01215380 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.00569803 |
| 16 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.99376489 |
| 17 | Retinol metabolism_Homo sapiens_hsa00830 | 1.92169571 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 1.89893378 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.88071233 |
| 20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.83563572 |
| 21 | Prion diseases_Homo sapiens_hsa05020 | 1.79970564 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.77430406 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.73196672 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.72620637 |
| 25 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.67021122 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.67018776 |
| 27 | * Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.59770521 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59651418 |
| 29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.56364471 |
| 30 | * Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56322045 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.53143686 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.42887302 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.39851812 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.33794664 |
| 35 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.33469540 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30978229 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29762700 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.27246024 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.15809174 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09532306 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.09398217 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07091721 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.02924187 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02256948 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02094967 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99984883 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96243339 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.95385545 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.94590145 |
| 50 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92315570 |
| 51 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92151467 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.90746010 |
| 53 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87616334 |
| 54 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83200732 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81735806 |
| 56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79442879 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78979953 |
| 58 | Peroxisome_Homo sapiens_hsa04146 | 0.78697938 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.75610736 |
| 60 | Galactose metabolism_Homo sapiens_hsa00052 | 0.75067066 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.73015528 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61481835 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59987179 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.54840147 |
| 65 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.53155394 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.52748048 |
| 67 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52001183 |
| 68 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.46816909 |
| 69 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.46063384 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45423908 |
| 71 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43007498 |
| 72 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42359839 |
| 73 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.42252282 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38581126 |
| 75 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37901861 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.36854969 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36493261 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.31850480 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.30928470 |
| 80 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.30639733 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.29209383 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.28007784 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.25949601 |
| 84 | Long-term potentiation_Homo sapiens_hsa04720 | 0.24259336 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.22992680 |
| 86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22664998 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.22042714 |
| 88 | Pertussis_Homo sapiens_hsa05133 | 0.20638025 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.20274958 |
| 90 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18900400 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17904936 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.13761192 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.13256144 |
| 94 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.13225110 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.12296125 |
| 96 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.11661424 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.10632835 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10582681 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.10434819 |
| 100 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.10434766 |

